Turkish renewable energy producer Yesil Global Enerji (PWRU.US) applies for listing in the United States with plans to raise up to $86 million.
Yesil Global Energy submitted its initial public offering application to the Securities and Exchange Commission (SEC) on Tuesday, aiming to raise up to $86 million.
Turkish landfill gas power operator Yesil Global Enerji (PWRU.US) submitted an initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC) on Tuesday, planning to raise up to $86 million.
Yesil Global Enerji is a Turkish renewable energy company that develops and operates landfill gas power plants, converting landfill gas and biogas generated from urban solid waste into grid-stable electricity.
The company operates six landfill gas power facilities in Turkey, including the Avcikoru power plant - the largest garbage power facility in the country in terms of electricity generation.
Yesil Global Enerji supplies electricity to the national grid and industrial customers in Turkey, and is evaluating the possibility of expanding into geothermal and natural gas projects in the United States through its wholly-owned subsidiary Power Upp USA.
Headquartered in Istanbul, Turkey, the company was founded in 2007 and recorded revenue of $53 million in the 12 months ending on June 30, 2025. The company plans to list on the Nasdaq under the ticker symbol PWRU.
Yesil Global Enerji secretly submitted the application on November 12, 2025. D. Boral Capital serves as the exclusive bookrunner for the transaction.
Related Articles

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!
Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


